CBD tested as new option for Hard-to-Control seizures

NCT ID NCT07233239

Recruiting now Disease control Sponsor: Jazz Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing whether a cannabidiol (CBD) oral solution can help reduce focal-onset seizures in people aged 12-75 who are already taking seizure medications. Researchers will measure how much the CBD reduces seizure frequency compared to before treatment and closely monitor safety. The study aims to see if this CBD formulation could become another treatment option for this type of epilepsy.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

ANESC Research
RECRUITING

El Paso, Texas, 79912, United States
Banner University Medical Center-Phoenix
NOT_YET_RECRUITING

Phoenix, Arizona, 85006, United States
Boston Children's Health Physicians
NOT_YET_RECRUITING

Hawthorne, New York, 10532, United States
Child Neurology & Consultants of Austin
RECRUITING

Austin, Texas, 78757, United States
Cincinnati Children's Hospital
NOT_YET_RECRUITING

Cincinnati, Ohio, 45229, United States
Corewell Health
NOT_YET_RECRUITING

Grand Rapids, Michigan, 49503, United States
Emory University
RECRUITING

Atlanta, Georgia, 30329, United States
Hackensack Meridian Neuroscience Institute at JFK University Medical Center
NOT_YET_RECRUITING

Edison, New Jersey, 08820, United States
Le Bonheur Children's Hospital
NOT_YET_RECRUITING

Memphis, Tennessee, 38103, United States
Mid-Atlantic Epilepsy and Sleep Center
RECRUITING

Bethesda, Maryland, 20817, United States
Northwestern University
NOT_YET_RECRUITING

Chicago, Illinois, 60611, United States
Onsite Clinical Solutions
RECRUITING

Charlotte, North Carolina, 28211, United States
Oregon Health & Science University
NOT_YET_RECRUITING

Portland, Oregon, 97239, United States
Saint Peter's University Hospital
RECRUITING

New Brunswick, New Jersey, 08901, United States
Savannah Neurology Specialists
RECRUITING

Savannah, Georgia, 31406, United States
Seattle Children's Hospital
NOT_YET_RECRUITING

Seattle, Washington, 98105, United States
UC San Diego
RECRUITING

La Jolla, California, 92037-1300, United States
University of Cincinnati, Gardner Neuroscience Institute
NOT_YET_RECRUITING

Cincinnati, Ohio, 45267-0525, United States
University of South Florida
NOT_YET_RECRUITING

Tampa, Florida, 33606, United States
Velocity Clinical Research at Raleigh Neurology
RECRUITING

Raleigh, North Carolina, 27607, United States
Wayne State University
NOT_YET_RECRUITING

Detroit, Michigan, 48201, United States
William S Middleton Memorial Veterans Hospital
NOT_YET_RECRUITING

Madison, Wisconsin, 53705, United States
Yale University
RECRUITING

New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.

FOCAL SEIZURES